Sarepta Therapeutics’ stock slips further as company bows to FDA pressure to halt shipments

4 months ago 16

ARTICLE AD BOX

Sarepta Therapeutics shares were lower in premarket trading on Tuesday, as the drugmaker relented to a Food and Drug Administration request to halt shipments of a gene therapy.

Read Entire Article

Sarepta Therapeutics’ stock slips further as company bows to FDA pressure to halt shipments

ARTICLE AD BOX

Related

As Alphabet’s stock rises and Nvidia’s pulls back, investors...

Apple and nine more tech companies that have treated their s...

Should I take Social Security at 62 so I can travel and take...

Trending

Popular

Can Pidcock win big & why did it end at Ineos?

Netflix scuttles plans to add six previously announced games...

‘I didn’t want to spend time with my children. I was just go...

‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided...

OpenAI co-founder John Schulman has left Anthropic after les...